![Kaisa Helminen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Kaisa Helminen
Directeur des opérations chez AIFORIA TECHNOLOGIES OYJ
Fortune : 637 433 $ au 31/05/2024
Postes actifs de Kaisa Helminen
Sociétés | Poste | Début | Fin |
---|---|---|---|
AIFORIA TECHNOLOGIES OYJ | Directeur des opérations | 01/07/2020 | - |
Directeur Général | 01/06/2014 | 01/07/2020 |
Historique de carrière de Kaisa Helminen
Anciens postes connus de Kaisa Helminen
Sociétés | Poste | Début | Fin |
---|---|---|---|
Sartorius Biohit Liquid Handling Oy
![]() Sartorius Biohit Liquid Handling Oy Electronic Equipment/InstrumentsElectronic Technology Part of Sartorius AG, Sartorius Biohit Liquid Handling Oy manufactures measuring and controlling devices. The company is based in Helsinki, Finland. | Corporate Officer/Principal | 01/05/2012 | 01/06/2014 |
Thermo Fisher Scientific Oy
![]() Thermo Fisher Scientific Oy Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific Oy is a Finnish company that manufactures and supplies medical and dental instruments. The company is based in Vanda, Finland. The CEO of the company is Timo Tapio Hildén. | Corporate Officer/Principal | 01/01/2011 | 01/05/2012 |
Finnzymes Oy
![]() Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Corporate Officer/Principal | 01/02/2001 | 01/01/2011 |
Formation de Kaisa Helminen
University of Helsinki | Graduate Degree |
Statistiques
Internationale
Finlande | 6 |
Opérationnelle
Corporate Officer/Principal | 3 |
Chief Executive Officer | 1 |
Chief Operating Officer | 1 |
Sectorielle
Health Technology | 3 |
Technology Services | 2 |
Electronic Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 1 |
---|---|
AIFORIA TECHNOLOGIES OYJ | Technology Services |
Entreprise privées | 3 |
---|---|
Sartorius Biohit Liquid Handling Oy
![]() Sartorius Biohit Liquid Handling Oy Electronic Equipment/InstrumentsElectronic Technology Part of Sartorius AG, Sartorius Biohit Liquid Handling Oy manufactures measuring and controlling devices. The company is based in Helsinki, Finland. | Electronic Technology |
Thermo Fisher Scientific Oy
![]() Thermo Fisher Scientific Oy Medical SpecialtiesHealth Technology Part of Thermo Fisher Scientific, Inc., Thermo Fisher Scientific Oy is a Finnish company that manufactures and supplies medical and dental instruments. The company is based in Vanda, Finland. The CEO of the company is Timo Tapio Hildén. | Health Technology |
Finnzymes Oy
![]() Finnzymes Oy Pharmaceuticals: MajorHealth Technology The company is part of Thermo Fisher Scientific, the world leader in serving science. Thermo Fisher Scientific enables customers to make the world healthier, cleaner and safer by providing analytical instruments, equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. With annual sales of more than $9 billion, Thermo Fisher Scientific has over 30,000 employees and serves more than 350,000 customers in pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies as well as environmental, industrial quality and process control settings. Finnzymes, founded in 1986, is a leader in the development of PCR, quantitative real-time PCR, transposon and RNA technologies. Its aim is to develop products which make the difference, products that deliver results not achievable otherwise. | Health Technology |
- Bourse
- Insiders
- Kaisa Helminen
- Expérience